business / news / / NDTV Profit
Novo Nordisk A/S will integrate OpenAI's artificial intelligence across the company to accelerate drug development.
Novo Nordisk will fully integrate OpenAI's AI across research, manufacturing, and commercial operations by year-end.
KEY POINTS
- The new OpenAI partnership extends beyond Novo's previous internal use of a custom ChatGPT version.
- Pilot programs using OpenAI's AI will start in R&D, manufacturing, and commercial units before full rollout.
- Novo aims to use OpenAI's AI to accelerate drug target identification and improve clinical trial design.
COMPANIES
Summarized by Newsio from NDTV Profit. How we summarize →